Evidence map›Paper›PMID 40108996›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Interactions between menopause and high-fat diet on cognition and pathology in a mouse model of Alzheimer's disease.

Charly Abi-Ghanem, Richard D Kelly, Emily A Groom, Caitlin G Valerian, Aaron S Paul, Christina A Thrasher, Abigail E Salinero, Molly R Batchelder, Jennifer J Lafrican, Matthew Wang and 4 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Charly Abi-GhanemDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.ORCID 0000-0003-3404-336X
Richard D KellyDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Emily A GroomDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Caitlin G ValerianDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Aaron S PaulDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Christina A ThrasherDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Abigail E SalineroDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Molly R BatchelderDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Jennifer J LafricanDepartment of Psychology and Center for Neuroscience Research, State University of New York at Albany, Albany, New York, USA.
Matthew WangDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Rachel M SmithDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.
Sally TempleNeural Stem Cell Institute, Albany, New York, USA.
Damian G ZuloagaDepartment of Psychology and Center for Neuroscience Research, State University of New York at Albany, Albany, New York, USA.
Kristen L ZuloagaDepartment of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, New York, USA.

Funding

Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular InteractionsU01AG072464 · NIA · REGENERATIVE RESEARCH FOUNDATION · PI HARARI, OSCAR, KAMPMANN, MARTIN · 2021 to 2025
$8.7M
Metabolic and Hormonal Mechanisms of VCIDR01NS110749 · NINDS · ALBANY MEDICAL COLLEGE · PI Kristen Leanne Zuloaga · 2019 to 2026
$4.3M
Alzheimer's Association 23AARGD-1024658Alzheimer's Association AARG-21-849204American Heart Association 908878BrightFocus Foundation A2022001FNIA NIH HHS U01 AG072464NINDS NIH HHS R01 NS110749
6 · The paper itself

Abstract

introductionPost-menopausal women constitute about two-thirds of those with Alzheimer's disease (AD). Menopause increases dementia risk by heightening the likelihood of metabolic disease, a well-known risk factor for dementia. We aimed to determine the effects of menopause and high-fat diet (HF) on cognitive and pathological outcomes in an AD mouse model.

methodsAt 3 months old, App

resultsAn interaction between HF diet and menopause led to impaired recognition memory. No effects of menopause were observed on amyloid pathology. However, menopause induced alterations in microglial response, white matter, and hippocampal neurogenesis. DISCUSSION: This work highlights the need to model endocrine aging in animal models of dementia and contributes to further understanding of the interaction between menopause and metabolic health in the context of AD. HIGHLIGHTS: The combination of menopause and HF diet led to early onset of cognitive impairment. HF diet increased amyloid pathology in the hippocampus. Menopause led to an increase in microglia density and a decrease in myelin in the corpus callosum. Menopause altered hippocampal neurogenesis in a diet-dependent manner.

Indexed as

Alzheimer DiseaseCognitionDiet, High-FatMenopauseAnimalsBrainCyclohexenesDisease Models, AnimalFemaleHippocampusMiceMice, TransgenicMicrogliaNeurogenesisVinyl Compounds4-vinyl-1-cyclohexene dioxideCyclohexenesVinyl CompoundsAlzheimer's diseaseamyloidmenopausemetabolic diseasemicroglianeurogenesiswhite matter

Identifiers

PMID40108996
PMCPMC11923387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.